摘要
目的:胰岛素不同注射方式治疗糖尿病的护理风险及疗效。方法选取2013年2月~2014年2月80例糖尿病患者,随机分为两组,每组40例。两组患者均给予重组人胰岛素注射治疗,其中对照组患者注射方法为多次皮下注射(MSII),观察组则为胰岛素泵持续皮下注射(CSII)。观察两组胰岛素用量、血糖达标时间与护理风险事件发生率。结果观察组空腹及餐后血糖指数改善明显优于对照组(P<0.05);观察组胰岛素用量、血糖达标时间明显少于对照组(P<0.05);观察组护理风险事件发生率明显低对照组(P<0.05)。结论胰岛素持续皮下输注对于糖尿病患者血糖的控制效果显著,护理风险低,值得推广应用。
Objective To observe care risks of insulin injection in different ways in the treatment of diabetes. Methods 80 cases of patients with diabetes from February 2013 to February 2014 in our hospital, were randomly divided into two groups, 40 cases of each group. Two groups of patients were treated with recombinant human insulin. Among them, the control group were given multiple subcutaneous (MSII), the experimental group were given continuous subcutaneous with in-sulin pump (CSII). Insulin dosage, blood glucose time and nursing risk event rate of the two groups were observed. Results The fasting and postprandial glycemic index in experimental group were significantly better than the control group (P<0.05); The insulin dosage, blood glucose target time in experimental group were significantly less than that in control group(P<0.05); The nursing risk event rate in experimental group was significantly lower than that in control group (P<0.05). Conclusion The treatment of continuous subcutaneous infusion of insulin for diabetics control blood glucose has many advantages,such as remarkable control effect, low care risks, and is wor-thy of popularization and application.
出处
《现代诊断与治疗》
CAS
2014年第20期4783-4784,4785,共3页
Modern Diagnosis and Treatment